GeoVax Labs, Inc.
GOVX
$1.28
-$0.06-4.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -- | 183.44% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -- | 183.44% | -- | -- |
| Cost of Revenue | -60.64% | -31.87% | 10.57% | 20.99% | 22.04% |
| Gross Profit | 55.60% | -9.32% | 2.50% | 16.00% | -8.18% |
| SG&A Expenses | -9.58% | 7.13% | 42.01% | 15.78% | 9.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -51.77% | -26.27% | 16.94% | 19.70% | 19.69% |
| Operating Income | 46.77% | -8.86% | -7.05% | 8.12% | -8.46% |
| Income Before Tax | 46.53% | -8.66% | -6.04% | 8.42% | -8.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 46.53% | -8.66% | -6.04% | 8.42% | -8.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.53% | -8.66% | -6.04% | 8.42% | -8.83% |
| EBIT | 46.77% | -8.86% | -7.05% | 8.12% | -8.46% |
| EBITDA | 46.85% | -9.14% | -7.22% | 8.11% | -8.49% |
| EPS Basic | 88.11% | 65.70% | 82.47% | 81.87% | 77.65% |
| Normalized Basic EPS | 88.11% | 65.70% | 82.47% | 81.87% | 77.65% |
| EPS Diluted | 88.11% | 65.70% | 82.47% | 81.87% | 77.65% |
| Normalized Diluted EPS | 88.11% | 65.70% | 82.47% | 81.87% | 77.65% |
| Average Basic Shares Outstanding | 349.56% | 216.74% | 504.72% | 404.96% | 387.12% |
| Average Diluted Shares Outstanding | 349.56% | 216.74% | 504.72% | 404.96% | 387.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |